BIOCELL2025，Vol.49Issue(10)：P.1799-1858,60.DOI:10.32604/biocell.2025.067216
Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions
Sotirios Charalampos Diamantoudis 1Androulla N.Miliotou 2Eleftheria Galatou 2Stergiani Telliou 3Konstantinos Sideris 4Nikolaos Grigoriadis 1Ioannis S.Vizirianakis5
作者信息
- 1. Laboratory of Pharmacology,School of Pharmacy,Faculty of Health Sciences,Aristotle University of Thessaloniki,Thessaloniki,54124,Greece
- 2. Department of Health Sciences,School of Life and Health Sciences,University of Nicosia,Nicosia,CY-1700,Cyprus
- 3. Department of Medicine,School of Health Sciences,Democritus University of Thrace,Alexandroupolis,68100,Greece
- 4. School of Medicine,Faculty of Health Sciences,Aristotle University of Thessaloniki,Thessaloniki,54124,Greece
- 5. Laboratory of Pharmacology,School of Pharmacy,Faculty of Health Sciences,Aristotle University of Thessaloniki,Thessaloniki,54124,Greece Department of Health Sciences,School of Life and Health Sciences,University of Nicosia,Nicosia,CY-1700,Cyprus
- 折叠
摘要
关键词
Hematological cancer stem cells(HCSCs)/immunotherapy/hematological cancer/cancer pathophysiology/leukaemia/lymphoma/monoclonal antibodies/CAR-T cells分类
医药卫生引用本文复制引用
Sotirios Charalampos Diamantoudis,Androulla N.Miliotou,Eleftheria Galatou,Stergiani Telliou,Konstantinos Sideris,Nikolaos Grigoriadis,Ioannis S.Vizirianakis..Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions[J].BIOCELL,2025,49(10):P.1799-1858,60.
